271 related articles for article (PubMed ID: 9754836)
1. Chemistry and pharmacology of hallucinogens, entactogens and stimulants.
Kovar KA
Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():69-72. PubMed ID: 9754836
[TBL] [Abstract][Full Text] [Related]
2. Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens.
Nichols DE
J Psychoactive Drugs; 1986; 18(4):305-13. PubMed ID: 2880944
[No Abstract] [Full Text] [Related]
3. Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting DOM, DOI, DOB, MDMA, and MBDB by spectral analysis of brain field potentials in the freely moving rat (Tele-Stereo-EEG).
Dimpfel W; Spüler M; Nichols DE
Psychopharmacology (Berl); 1989; 98(3):297-303. PubMed ID: 2568652
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus effects of psychostimulants and hallucinogens in S(+)-3,4-methylenedioxymethamphetamine (MDMA) and R(-)-MDMA trained mice.
Murnane KS; Murai N; Howell LL; Fantegrossi WE
J Pharmacol Exp Ther; 2009 Nov; 331(2):717-23. PubMed ID: 19684254
[TBL] [Abstract][Full Text] [Related]
5. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
Callahan PM; Appel JB
J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
[TBL] [Abstract][Full Text] [Related]
6. Rewarding effects of the optical isomers of 3,4-methylenedioxy-methylamphetamine ('Ecstasy') and 3,4-methylenedioxy-ethylamphetamine ('Eve') measured by conditioned place preference in rats.
Meyer A; Mayerhofer A; Kovar KA; Schmidt WJ
Neurosci Lett; 2002 Sep; 330(3):280-4. PubMed ID: 12270646
[TBL] [Abstract][Full Text] [Related]
7. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
Oberlender R; Nichols DE
J Pharmacol Exp Ther; 1990 Dec; 255(3):1098-106. PubMed ID: 1979813
[TBL] [Abstract][Full Text] [Related]
8. Behavioral profiles in rats distinguish among "ecstasy," methamphetamine and 2,5-dimethoxy-4-iodoamphetamine: Mixed effects for "ecstasy" analogues.
Quinteros-Muñoz D; Sáez-Briones P; Díaz-Véliz G; Mora-Gutiérrez S; Rebolledo-Fuentes M; Cassels BK
Behav Neurosci; 2010 Oct; 124(5):662-76. PubMed ID: 20939666
[TBL] [Abstract][Full Text] [Related]
9. Altered states: the clinical effects of Ecstasy.
Cole JC; Sumnall HR
Pharmacol Ther; 2003 Apr; 98(1):35-58. PubMed ID: 12667887
[TBL] [Abstract][Full Text] [Related]
10. [Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].
Gouzoulis-Mayfrank E; Hermle L; Kovar KA; Sass H
Nervenarzt; 1996 May; 67(5):369-80. PubMed ID: 9005345
[TBL] [Abstract][Full Text] [Related]
11. MDA, MDMA, and other "mescaline-like" substances in the US military's search for a truth drug (1940s to 1960s).
Passie T; Benzenhöfer U
Drug Test Anal; 2018 Jan; 10(1):72-80. PubMed ID: 28851034
[TBL] [Abstract][Full Text] [Related]
12. The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA).
Freudenmann RW; Spitzer M
CNS Drug Rev; 2004; 10(2):89-116. PubMed ID: 15179441
[TBL] [Abstract][Full Text] [Related]
13. MDMA-like stimulus effects of alpha-ethyltryptamine and the alpha-ethyl homolog of DOM.
Glennon RA
Pharmacol Biochem Behav; 1993 Oct; 46(2):459-62. PubMed ID: 7903460
[TBL] [Abstract][Full Text] [Related]
14. The many faces of ecstasy.
Doyon S
Curr Opin Pediatr; 2001 Apr; 13(2):170-6. PubMed ID: 11317061
[TBL] [Abstract][Full Text] [Related]
15. Receptor pharmacology of MDMA and related hallucinogens.
Teitler M; Leonhardt S; Appel NM; De Souza EB; Glennon RA
Ann N Y Acad Sci; 1990; 600():626-38; discussion 638-9. PubMed ID: 1979215
[TBL] [Abstract][Full Text] [Related]
16. Increasing use of "Ecstasy" (MDMA) and other hallucinogens on a college campus.
Cuomo MJ; Dyment PG; Gammino VM
J Am Coll Health; 1994 May; 42(6):271-4. PubMed ID: 7913938
[TBL] [Abstract][Full Text] [Related]
17. Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.
Dunlap LE; Andrews AM; Olson DE
ACS Chem Neurosci; 2018 Oct; 9(10):2408-2427. PubMed ID: 30001118
[TBL] [Abstract][Full Text] [Related]
18. Serotonergic mechanisms of hallucinogenic drug effects.
Heym J; Jacobs BL
Monogr Neural Sci; 1987; 13():55-81. PubMed ID: 2891030
[No Abstract] [Full Text] [Related]
19. [Ecstasy: from recreational drug to toxic substance].
Franck N; Bertrand J
Rev Med Liege; 1997 Nov; 52(11):715-22. PubMed ID: 9480498
[No Abstract] [Full Text] [Related]
20. Information on "Ecstasy".
Greer G; Strassman RJ
Am J Psychiatry; 1985 Nov; 142(11):1391. PubMed ID: 2865906
[No Abstract] [Full Text] [Related]
[Next] [New Search]
